Navigation Links
Human Genome Sciences Announces Positive Final Results Of Phase 2b,Trial of Albuferon

response offered by the 1200-microgram dose on a two-week administration schedule," said Dr. Stump.

    Albuferon 1200-mcg Monthly (Albuferon 1200 Q4w)


    -- ITT analysis shows that 50.9% of patients in the Albuferon 1200 Q4w

       treatment group achieved SVR, vs. 57.9% for Pegasys administered every

       week.

    -- In heavier patients (>75 kg) who were treatment-adherent, 61.0% of

       those in the Albuferon 1200 Q4w treatment group achieved SVR, versus

       53.3% for Pegasys administered once every week.

    -- Among all treatment-adherent patients in the Albuferon 1200 Q4w

       treatment group, 62.0% achieved SVR, versus 66.7% for Pegasys.

    -- The rate of discontinuations due to adverse events was 12.1% in the

       Albuferon 1200 Q4w treatment group, vs. 6.1% in the Pegasys group.

    -- The number of patients experiencing severe hematologic adverse events

       was significantly lower in the Albuferon 1200 Q4w treatment group

       (10.3%, vs. 23.7% for Pegasys, p=0.006).

"We are encouraged that more than half of the patients achieved sustained virologic response in the treatment group receiving Albuferon 1200-mcg once every month," said Dr. Stump. "These data, along with emerging Phase 2 data for a monthly 1500-mcg dose, provide an excellent rationale for the study that we and our collaborator, Novartis, are currently planning to evaluate higher doses of Albuferon administered monthly."

The top-line final Phase 2b results include data through Week 24 following completion of 48 weeks of therapy. The open-label, multi-center, active- controlled, dose-ranging trial enrolled and randomized 458 patients with genotype 1 chronic hepatitis C. Patients were randomized into four treatment groups, three of which received subcutaneously administered Albuferon (900 mcg every two weeks, 1200 mcg every two weeks, and 1200 mcg every four weeks). The fourth treatment group served as the active control group and recei
'"/>




Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Testing for Human Papillomavirus
2. Bio-Matrix Scientifics Dr. ONeill Sees University of Pittsburghs Published Study on Culture Blood-Forming Stem Cells from Human Fat Tissue as Supporting Near Term Benefits of Banking Adipose (Fat) Derived Stem Cells
3. Phase II Results Show Once-Daily Dosing of Human GLP-1 Analog Liraglutide, Brings Patients to A1c Target
4. Advanced Cell Technology Develops First Human Embryonic Stem Cell Line without Destroying an Embryo
5. Modigene Announces Successful Completion of Pharmacokinetic & Pharmacodynamic Pre-Clinical Experiments for Proprietary Long-Acting Human Growth Hormone, Long-acting Interferon Beta and Long-acting Erythropoietin
6. Second Successful Quigley QR-443 Study Suggests Method of Action Relevant to Broad Range of Chronic Inflammatory Diseases - Human Study to Follow -
7. Research Documents Scalable Production, Survival Following Engraftment and Positive Impact on Cardiac Function in Infarcted Rats for Gerons Human Embryonic Stem Cell-Based Therapeutic for Heart Failure
8. Human Genome Sciences Reports That a Phase 2 Study of LymphoStat-B Showed Significant Reductions in Disease Activity in Patients with Active Systemic Lupus Erythematosus
9. NCI Researchers Discover Genes That Are Turned on at High Levels in Tumor-associated Blood Vessels of Mice and Humans
10. Research Indicates Gerons Human Embryonic Stem Cell-Based Therapeutic for Spinal Cord Injury Evades Direct Attack by the Human Immune System
11. Mymetics HIV Vaccine Demonstrates First-Ever Production of Neutralizing IgA Antibodies in Non-Human Primate Model
Post Your Comments:
(Date:5/22/2013)... 22, 2013  Healthcare providers are turning ... management (ECM) solution, for a deeper ... .  These organizations identified enterprise content management ... use OnBase to optimize their Meditech system ... (Logo:  http://photos.prnewswire.com/prnh/20090130/65710LOGO  ) ...
(Date:5/22/2013)... NEW YORK , May 22, 2013 ... Gross LLP is investigating claims on behalf of investors ... (NASDAQ: ISRG ) (CUSIP: 46120E602) who purchased ... April 18, 2013 (the "Class Period"). Such investors are ... at rswilloughby@pomlaw.com or 888-476-6529, ext. 237. ...
(Date:5/22/2013)... , May 22, 2013  MGT Capital Investments, ... will present at the Second Annual Marcum LLP MicroCap ... New York City at the Grand Hyatt ... Chief Executive Officer, will update investors and answer questions. ... The Company,s presentation is scheduled to begin at 9:30 ...
Breaking Medicine Technology:Three New Health Systems Integrate Hyland Software's OnBase with Meditech Hospital Information System 2Three New Health Systems Integrate Hyland Software's OnBase with Meditech Hospital Information System 3SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Intuitive Surgical, Inc. - ISRG 2MGT Capital Investments, Inc. To Present At The Second Annual Marcum LLP MicroCap Conference 2MGT Capital Investments, Inc. To Present At The Second Annual Marcum LLP MicroCap Conference 3MGT Capital Investments, Inc. To Present At The Second Annual Marcum LLP MicroCap Conference 4
... Macular ... ... privately held ophthalmic pharmaceutical company, announced today that,enrollment has been completed ... of its lead product, IBI-20089, in patients with,cystoid macular edema. This ...
... ... combination therapy High SVR 24 rate ... Schering-Plough,Corporation (NYSE: SGP ) today reported top-line results from a planned,interim ... protease inhibitor. The analysis showed a high rate of,sustained virologic response (SVR) ...
Cached Medicine Technology:Icon Bioscience Completes Enrollment in Phase I Study of Novel Ophthalmic Drug Candidate 2Top-Line Results of Boceprevir Phase II Study Showed High Rate of Sustained Response (SVR) in Genotype 1 Treatment-Naive Hepatitis C Patients 2Top-Line Results of Boceprevir Phase II Study Showed High Rate of Sustained Response (SVR) in Genotype 1 Treatment-Naive Hepatitis C Patients 3Top-Line Results of Boceprevir Phase II Study Showed High Rate of Sustained Response (SVR) in Genotype 1 Treatment-Naive Hepatitis C Patients 4Top-Line Results of Boceprevir Phase II Study Showed High Rate of Sustained Response (SVR) in Genotype 1 Treatment-Naive Hepatitis C Patients 5Top-Line Results of Boceprevir Phase II Study Showed High Rate of Sustained Response (SVR) in Genotype 1 Treatment-Naive Hepatitis C Patients 6Top-Line Results of Boceprevir Phase II Study Showed High Rate of Sustained Response (SVR) in Genotype 1 Treatment-Naive Hepatitis C Patients 7Top-Line Results of Boceprevir Phase II Study Showed High Rate of Sustained Response (SVR) in Genotype 1 Treatment-Naive Hepatitis C Patients 8Top-Line Results of Boceprevir Phase II Study Showed High Rate of Sustained Response (SVR) in Genotype 1 Treatment-Naive Hepatitis C Patients 9
(Date:5/23/2013)... May 23, 2013 After working continuously ... beta testing regimes, Shopping Cart Elite officially ... Redsandmotorsports.com is an Arizona based online store retailing in ... , “Addition of new stores to our clientele has ... Cart Elite, Igor Soshkin. “We are extremely elated with ...
(Date:5/23/2013)... 23, 2013 FindUrgentCare.com launched updates to ... search option for patients. The new advanced feature ... including payment preferences, offered services, insurances accepted and hours ... way to narrow their search and receive targeted results ... provide ambulatory care to walk-in patients in a non-emergency, ...
(Date:5/23/2013)... 2013 Greenville Oral & Maxillofacial ... members and doctors have recently completed their bi-annual ... an Automated External Defibrillator (AED). ... medical device designed to analyze the heart rhythm ... ventricular fibrillation to restore the heart rhythm to ...
(Date:5/23/2013)... 23, 2013 Great defined abs are the ... everyone strives to achieve in the gym yet so many ... not make this goal become a reality. Great abdominal muscles ... often time overlooked. Scott Tischler of Tischler Brothers Fitness explains ... achieve the goal of great abs. , 1.    Go to bed ...
(Date:5/23/2013)... 2013 PhD Box has introduced ... of the research process by offering assistance for Thesis Proposals. ... repertoire of services that the company provides for research consultation ... a dedicated proposal writing service is that this is the ... the research process find it difficult to draft a proposal ...
Breaking Medicine News(10 mins):Health News:Shopping Cart Software Provider, Shopping Cart Elite Officially Announces the Launch Of Redsandmotorsports.com 2Health News:Find Urgent Care Launches New Site Design and Functionality to Provide Advanced Search Options for Users in Need of an Urgent Care Clinic 2Health News:Find Urgent Care Launches New Site Design and Functionality to Provide Advanced Search Options for Users in Need of an Urgent Care Clinic 3Health News:Greenville Oral & Maxillofacial Surgeons Announce CPR Re-Certification 2Health News:Scott Tischler of Tischler Brothers Fitness Unveils the 4 Secrets to Getting Abs this Summer 2Health News:PhD Box Unveils Proposal Writing Services for Research Scholars 2
... HOUSTON, Jan. 6 Bederra Corporation (Pink Sheets: BEDA), the ... of Directors has approved a 1 for 400 reverse split ... as of December 03, 2008. The Company has submitted all ... new trading symbol; it began trading on a post-split basis ...
... What and When , Music industry veteran and TV ... Association for a second year to help people living with ... disease, and to encourage them to enroll in The ... 2 diabetes, is coming to Philadelphia to urge the tens ...
... pancreatic cancer patient,has become the first person in Italy ... that potentially enables doctors to improve outcomes while,extending more ... Milan,delivered the faster treatment using RapidArc(TM) radiotherapy technology from,Varian ... "We see three major benefits with ...
... Nutrition Fit For the Whole Family in 2009 Without the ... New Year,s Resolutions, getting fit and eating better are usually ... are healthier than their prepared or quick-service counterparts all too ... Nutritionist Claudia Gonzalez is helping those making the resolution to ...
... NxStage Medical, Inc. (Nasdaq: NXTM ), ... that a group of its first patients are celebrating ... NxStage(R) System One(TM), the first truly portable home hemodialysis ... improved quality of life characterized by better health and ...
... MYL ) today announced that it will present ... 13, at 8:30 a.m. PST at the Westin St. Francis ... and live audio web cast by visiting the Investor Relations, ... clicking on the event icon. Following the live web ...
Cached Medicine News:Health News:Bederra Corp. Approves 1-for-400 Reverse Stock Split 2Health News:Randy Jackson and the American Heart Association Encourage Philadelphia Residents to 'Get In The K.N.O.W.' About Improving Type 2 Diabetes Management 2Health News:First RapidArc Radiotherapy Treatment in Italy Takes Place at Leading Milan Cancer Center 2Health News:First RapidArc Radiotherapy Treatment in Italy Takes Place at Leading Milan Cancer Center 3Health News:Nutritionist Claudia Gonzalez Shows How New Year's Resolutions Are Easy to Keep 2Health News:First NxStage Home Hemodialysis Patients Celebrate Five-Year Anniversary 2Health News:First NxStage Home Hemodialysis Patients Celebrate Five-Year Anniversary 3Health News:First NxStage Home Hemodialysis Patients Celebrate Five-Year Anniversary 4
Wedge-shaped chopper designed to allow nucleus chopping in three directions, tip length 1.25 mm. Rounded tip highly polished to protect the posterior capsule. 0.5 mm spatula end is used to manipulate...
11 mm angled tip with gently curved blade. Flat serrated handle with polished finish....
0.5 mm x 10 mm angled blade with blunt tip. Flat smooth handle with polished finish....
Tip is placed in the side port incision and into the groove. When squeeze handle is activated tip rotates nucleus....
Medicine Products: